A Discussion of COPD Surveillance Data

Published Online: Friday, January 17, 2014
Follow Pharmacy_Times:
In this podcast, Earl S. Ford, MD, MPH and David M. Mannino, MD, FCCP, discuss their study of surveillance results for COPD in the United States from 1999 to 2011 with CHEST podcast editor D. Kyle Hogarth, MD, FCCP.

To listen to this podcast, click here.
Related Articles
Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, details some factors that contribute to nonadherence among patients with COPD.
Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the importance of individualizing treatment for COPD.
Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the burden COPD places on society.
Chronic obstructive pulmonary disease Is preventable and treatable, especially if diagnosed early.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$